Closing date: 17 Dec 2023
Responsibilities:
- Provide in-depth knowledge and scientific leadership to establish and validate cell-based, molecular, and biochemical assays
- Ensure reliability and reproducibility of screening results and methods, and appropriate data analysis and interpretation to support decision making
- Leverage lab automation to improve assay operation, quality, and overall productivity
- Evaluate and implement new enabling technologies and methods
- Lead early discovery projects from idea conception to proof of mechanism/concept or principle
- Partner with project and functional teams in a matrix environment
- Responsible for effective project management and utilization of internal and external resources.
- Mentor, motivate and develop junior scientists and research associates, contribute to building a positive and results-oriented culture
Qualifications and skills:
- PhD in a life science disciplines with minimal three years of industry experience
- Extensive hands-on experience in establishing novel and standard cell-based, molecular, and biochemical medium/high throughput screening assays
- Hands-on experience with various automated liquid handling instruments and robotic systems for assay operation
- Strong data processing and analysis skills covering single point and dose response analyses
- Experience in independently developing and testing scientific hypotheses based on human disease pathogenesis and drug MOA in various therapeutic areas
- Demonstrated ability to work collaboratively in a cross-functional team environment to advance drug discovery, with excellent organization and communication skills
- Prior experience training, supervising and mentoring associate scientists
- Prior experience with multiple therapeutic modalities (small molecule, peptide, antibody, antibody drug conjugate, etc.) is a plus
Please email your applications to: Yuhui.huang@beigene.com
[tds_leads title_text="Get notified whenever new job listings are added" input_placeholder="Your email address" btn_horiz_align="content-horiz-center" pp_checkbox="yes" pp_msg="SSd2ZSUyMHJlYWQlMjBhbmQlMjBhY2NlcHQlMjB0aGUlMjAlM0NhJTIwaHJlZiUzRCUyMmh0dHBzJTNBJTJGJTJGd3d3LnRyb3BpY2FsaGFpbmFuLmNvbSUyRnRyb3BpY2FsaGFpbmFuLXByaXZhY3ktcG9saWN5JTJGJTIyJTNFUHJpdmFjeSUyMFBvbGljeSUzQyUyRmElM0Uu" msg_composer="error" msg_pos="form" msg_space="30px 0 0 0" msg_padd="10px 20px" unsub_msg="WW91J3JlJTIwYWxyZWFkeSUyMHN1YnNjcmliZWQlMjB3aXRoJTIwdGhpcyUyMGVtYWlsJTIwYWRkcmVzcyE=" display="" el_class="td-leads-amsonia" gap="10" input_border="1px" all_btn_border="1px" tdc_css="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" f_title_font_family="976" f_msg_font_family="976" f_input_font_family="976" f_title_font_size="eyJhbGwiOiIyNCIsInBvcnRyYWl0IjoiMjAiLCJwaG9uZSI6IjIwIn0=" f_title_font_line_height="1.2" f_title_font_weight="700" f_msg_font_size="eyJhbGwiOiIxMiIsInBvcnRyYWl0IjoiMTAifQ==" f_msg_font_line_height="1.2" f_msg_font_weight="400" f_input_font_size="eyJhbGwiOiIxNiIsInBvcnRyYWl0IjoiMTQiLCJwaG9uZSI6IjE0In0=" f_input_font_transform="" f_input_font_line_height="1.2" f_msg_font_transform="uppercase" f_msg_font_spacing="2" f_unsub_font_family="976" f_btn_font_family="976" f_unsub_font_size="10" f_unsub_font_spacing="2" f_unsub_font_weight="400" f_unsub_font_transform="uppercase" f_btn_font_line_height="1.2" f_btn_font_weight="400" f_btn_font_spacing="2" f_btn_font_transform="uppercase" f_unsub_font_line_height="1.2" f_btn_font_size="10" btn_bg="var(--amsonia-off-white)" btn_color="var(--amsonia-gray)" btn_color_h="var(--amsonia-primary-color)" all_btn_border_color="var(--amsonia-gray)" btn_border_color_h="var(--amsonia-primary-color)" title_color="var(--reel-news-accent)" input_place_color="var(--amsonia-gray)" input_color="var(--amsonia-dark)" input_bg="var(--amsonia-off-white)" input_bg_f="var(--amsonia-off-white)" input_border_color="var(--amsonia-gray)" input_border_color_f="var(--amsonia-primary-color)" btn_bg_h="var(--amsonia-off-white)" pp_check_border_color="var(--amsonia-gray)" pp_check_border_color_c="var(--amsonia-primary-color)" pp_check_bg="var(--amsonia-off-white)" pp_check_bg_c="var(--amsonia-off-white)" pp_check_square="var(--amsonia-primary-color)" pp_check_color="var(--amsonia-gray)" pp_check_color_a="var(--amsonia-primary-color)" pp_check_color_a_h="var(--amsonia-accent-color)" f_pp_font_family="976" f_pp_font_size="12" f_pp_font_line_height="1.2" f_pp_font_weight="400" msg_succ_bg="rgba(0,0,0,0)" all_msg_succ_border_color="var(--amsonia-accent-color)" msg_succ_color="var(--amsonia-accent-color)" all_msg_succ_border="1px" all_msg_err_border="1px" msg_error_color="var(--amsonia-dark)" all_msg_err_border_color="var(--amsonia-dark)" msg_err_bg="rgba(0,0,0,0)" title_tag="" show_version="" title_space="20" list="842"]
